Sanofi (EPA:SAN)
84.51
-0.18 (-0.21%)
Sep 2, 2025, 5:37 PM CET
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
€551,871
Profits / Employee
€110,114
Market Cap
103.06B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
Dec 31, 2020 | 99,412 | -997 | -0.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
ABIVAX Société Anonyme | 69 |
Virbac | 6,365 |
emeis Société anonyme | 83,494 |
Sanofi News
- 8 hours ago - Sanofi (SNY) Receives Upgrade from Deutsche Bank | SNY Stock News - GuruFocus
- 17 hours ago - Sanofi CEO: AI might beat IQ, not EQ — but never say never - Fortune
- 3 days ago - Sanofi's (SNY) Wayrilz Gains FDA Approval for ITP Treatment - GuruFocus
- 3 days ago - Sanofi wins FDA nod for Wayrilz in bleeding disorder thrombocytopenia - Seeking Alpha
- 3 days ago - Now Is The Time To Buy This High-Yielding Trio - Seeking Alpha
- 4 days ago - US FDA approves Sanofi's drug for a rare blood disorder - Reuters
- 4 days ago - Press Release: Sanofi's Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia - Benzinga
- 4 days ago - Press Release: Sanofi's Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia - GlobeNewsWire